Achieve Life Sciences, Inc. Business Combination, Contingent Consideration, Liability, Current
Achieve Life Sciences, Inc. (ACHV) had Business Combination, Contingent Consideration, Liability, Current of $1.37 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2026-08-11
- 2026-06-30: Business Combination, Contingent Consideration, Liability, Current $1.37M.
- 2026-03-31: Business Combination, Contingent Consideration, Liability, Current $0.00.
- 2025-12-31: Business Combination, Contingent Consideration, Liability, Current $1.56M.
- 2025-09-30: Business Combination, Contingent Consideration, Liability, Current $1.44M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2026-06-30 | $1.37M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 |
| 2025-12-31 | $1.56M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $1.44M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.34M 10-Q · filed 2025-08-07 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-24 |
| 2023-12-31 | $528.00K 10-K · filed 2025-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |